Cargando…
A randomized, double blind, parallel, placebo‐controlled study to investigate the efficacy of Lactobacillus paracasei N1115 in gut development of young children
In this clinical trial, the safety and effectiveness of Lactobacillus paracasei N1115 (LP N1115) were investigated as a potential probiotic to enhance gut development in young children born by caesarean section. Infants and young children between the ages of 6 months and 3 years were administered wi...
Autores principales: | Wang, Shijie, Xun, Yiping, Ahern, Grace J., Feng, Lili, Zhang, Dong, Xue, Yuling, Ross, Reynolds Paul, Doolan, Andrea M., Stanton, Catherine, Zhu, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8565250/ https://www.ncbi.nlm.nih.gov/pubmed/34760234 http://dx.doi.org/10.1002/fsn3.2533 |
Ejemplares similares
-
Effect of Lacticaseibacillus paracasei N1115 on Immunomodulatory and Gut Microbial Composition in Young Children: A Randomized, Placebo-Controlled Study
por: Li, Pin, et al.
Publicado: (2023) -
Effect of heat-inactivated Lactobacillus paracasei N1115 on microbiota and gut-brain axis related molecules
por: ZHANG, Yujie, et al.
Publicado: (2020) -
Whole Genome Sequence of the Probiotic Strain Lactobacillus paracasei N1115, Isolated from Traditional Chinese Fermented Milk
por: Wang, Shijie, et al.
Publicado: (2014) -
Effect of Lactobacillus paracasei N1115 and fructooligosaccharides in nonalcoholic fatty liver disease
por: Yao, Fangfang, et al.
Publicado: (2019) -
Lactobacillus paracasei
N1115 attenuates obesity in high‐fat diet‐induced obese mice
por: Sun, Yanan, et al.
Publicado: (2022)